Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 3/2020

19.11.2019 | Case Report

Congestive hepatopathy and acute pancreatitis as severe complications of mixed connective tissue disease

verfasst von: Shigekazu Kurihara, Takefumi Kimura, Naoki Tanaka, Takumi Yanagisawa, Hiroyuki Kobayashi, Keita Kanai, Takeji Umemura, Mamoru Kobayashi, Hiromitsu Mori, Shuichi Wada

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Mixed connective tissue disease (MCTD) causes multiple organ dysfunctions, such as joint swelling, pulmonary fibrosis and hypertension, and serositis, but hepatopancreatic complications are rare. Here, we report a case of young man who exhibited acute severe liver dysfunction. He also had impaired cardiac function: both ventriculi were hypokinetic, but pulmonary hypertension and pericarditis were not observed. Since his liver and cardiac function markedly improved after commencing furosemide and carperitide, we considered congestive hepatopathy due to MCTD and accompanying heart failure. Heart failure and congestive hepatopathy recurred and he was treated with diuretics and prednisolone, but he passed away by co-occurrence of acute hemorrhagic pancreatitis. Necropsy revealed chronic hepatic congestion but not accompanying autoimmune hepatitis and hepatic vasculitis. We should consider congestive hepatopathy and hemorrhagic pancreatitis as serious complications of MCTD.
Literatur
1.
Zurück zum Zitat Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148–59.CrossRef Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148–59.CrossRef
2.
Zurück zum Zitat Burdt MA, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899–909.CrossRef Burdt MA, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899–909.CrossRef
3.
Zurück zum Zitat Gunnarsson R, Aalokken TM, Molberg O, et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis. 2012;71:1966–72.CrossRef Gunnarsson R, Aalokken TM, Molberg O, et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis. 2012;71:1966–72.CrossRef
4.
Zurück zum Zitat Hajas A, Szodoray P, Nakken B, et al. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol. 2013;40:1134–42.CrossRef Hajas A, Szodoray P, Nakken B, et al. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol. 2013;40:1134–42.CrossRef
5.
Zurück zum Zitat Marshall JB, Kretschmar JM, Gerhardt DC, et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology. 1990;98:1232–8.CrossRef Marshall JB, Kretschmar JM, Gerhardt DC, et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology. 1990;98:1232–8.CrossRef
6.
Zurück zum Zitat Amigues JM, Cantagrel A, Abbal M, et al. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol. 1996;23:2055-62. Amigues JM, Cantagrel A, Abbal M, et al. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol. 1996;23:2055-62.
7.
Zurück zum Zitat Chan KL, Currie PJ, Seward JB, et al. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol. 1987;9:549–54.CrossRef Chan KL, Currie PJ, Seward JB, et al. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol. 1987;9:549–54.CrossRef
8.
Zurück zum Zitat Yokoe M, Takada T, Mayumi T, et al. Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. J Hepatobiliary Pancreat Sci. 2015;22:405–32.CrossRef Yokoe M, Takada T, Mayumi T, et al. Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. J Hepatobiliary Pancreat Sci. 2015;22:405–32.CrossRef
9.
Zurück zum Zitat Gelow JM, Desai AS, Hochberg CP, et al. Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail. 2010;3:59–64.CrossRef Gelow JM, Desai AS, Hochberg CP, et al. Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail. 2010;3:59–64.CrossRef
10.
Zurück zum Zitat de Boer YS, van Nieuwkerk CM, Witte BI, et al. Assessment of the histopathological key features in autoimmune hepatitis. Histopathology. 2015;66:351–62.CrossRef de Boer YS, van Nieuwkerk CM, Witte BI, et al. Assessment of the histopathological key features in autoimmune hepatitis. Histopathology. 2015;66:351–62.CrossRef
11.
Zurück zum Zitat Umemura T, Katsuyama Y, Yoshizawa K, et al. Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan. PLoS ONE. 2014;23(9):e100565.CrossRef Umemura T, Katsuyama Y, Yoshizawa K, et al. Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan. PLoS ONE. 2014;23(9):e100565.CrossRef
12.
Zurück zum Zitat Marshall JB, Ravendhran N, Sharp GC. Liver disease in mixed connective tissue disease. Arch Intern Med. 1983;143:1817–8.CrossRef Marshall JB, Ravendhran N, Sharp GC. Liver disease in mixed connective tissue disease. Arch Intern Med. 1983;143:1817–8.CrossRef
13.
Zurück zum Zitat Wong GW, Heneghan MA. Association of extrahepatic manifestations with autoimmune hepatitis. Dig Dis. 2015;33(Suppl 2):25–35.CrossRef Wong GW, Heneghan MA. Association of extrahepatic manifestations with autoimmune hepatitis. Dig Dis. 2015;33(Suppl 2):25–35.CrossRef
14.
Zurück zum Zitat Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.CrossRef Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.CrossRef
15.
Zurück zum Zitat Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRef Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRef
16.
Zurück zum Zitat Lundberg IE. Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus. 2005;14:708–12.CrossRef Lundberg IE. Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus. 2005;14:708–12.CrossRef
17.
Zurück zum Zitat Pinamonti B, Alberti E, Cigalotto A, et al. Echocardiographic findings in myocarditis. Am J Cardiol. 1988;62:285–91.CrossRef Pinamonti B, Alberti E, Cigalotto A, et al. Echocardiographic findings in myocarditis. Am J Cardiol. 1988;62:285–91.CrossRef
18.
Zurück zum Zitat Witczak BN, Hetlevik SO, Sanner H, et al. Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study. J Rheumatol. 2019;46:739–47.CrossRef Witczak BN, Hetlevik SO, Sanner H, et al. Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study. J Rheumatol. 2019;46:739–47.CrossRef
19.
Zurück zum Zitat Braun J, Sieper J, Schwarz A, et al. Widespread vasculopathy with hemolytic uremic syndrome, perimyocarditis and cystic pancreatitis in a young woman with mixed connective tissue disease. Case report and review of the literature. Rheumatol Int. 1993;13:31-6.CrossRef Braun J, Sieper J, Schwarz A, et al. Widespread vasculopathy with hemolytic uremic syndrome, perimyocarditis and cystic pancreatitis in a young woman with mixed connective tissue disease. Case report and review of the literature. Rheumatol Int. 1993;13:31-6.CrossRef
20.
Zurück zum Zitat Nishida S, Fujimoto T, Usui T, et al. Mixed connective tissue disease (MCTD) with severe acute pancreatitis. Nihon Naika Gakkai Zasshi. 2001;90:1518-21.CrossRef Nishida S, Fujimoto T, Usui T, et al. Mixed connective tissue disease (MCTD) with severe acute pancreatitis. Nihon Naika Gakkai Zasshi. 2001;90:1518-21.CrossRef
21.
Zurück zum Zitat Nanke Y, Kotake S, Fukasawa C, et al. A case of mixed connective tissue disease with cystic pancreatitis: successful treatment by cyclophosphamide. J Clin Rheumatol. 2001;7:131-3 Nanke Y, Kotake S, Fukasawa C, et al. A case of mixed connective tissue disease with cystic pancreatitis: successful treatment by cyclophosphamide. J Clin Rheumatol. 2001;7:131-3
22.
Zurück zum Zitat Kloppel G. Pseudocysts and other non-neoplastic cysts of the pancreas. Semin Diagn Pathol. 2000;17:7–15. Kloppel G. Pseudocysts and other non-neoplastic cysts of the pancreas. Semin Diagn Pathol. 2000;17:7–15.
23.
Zurück zum Zitat Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39:709–16.CrossRef Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39:709–16.CrossRef
24.
Zurück zum Zitat Baysal B, Kayar Y, Ozmen A, et al. Olanzapine-induced acute pancreatitis. Turk J Gastroenterol. 2015;26:289–90.CrossRef Baysal B, Kayar Y, Ozmen A, et al. Olanzapine-induced acute pancreatitis. Turk J Gastroenterol. 2015;26:289–90.CrossRef
25.
Zurück zum Zitat Pascual-Ramos V, Duarte-Rojo A, Villa AR, et al. Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis. J Rheumatol. 2004;31:707–12. Pascual-Ramos V, Duarte-Rojo A, Villa AR, et al. Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis. J Rheumatol. 2004;31:707–12.
26.
Zurück zum Zitat Breuer GS, Baer A, Dahan D, et al. Lupus-associated pancreatitis. Autoimmun Rev. 2006;5:314–8.CrossRef Breuer GS, Baer A, Dahan D, et al. Lupus-associated pancreatitis. Autoimmun Rev. 2006;5:314–8.CrossRef
Metadaten
Titel
Congestive hepatopathy and acute pancreatitis as severe complications of mixed connective tissue disease
verfasst von
Shigekazu Kurihara
Takefumi Kimura
Naoki Tanaka
Takumi Yanagisawa
Hiroyuki Kobayashi
Keita Kanai
Takeji Umemura
Mamoru Kobayashi
Hiromitsu Mori
Shuichi Wada
Publikationsdatum
19.11.2019
Verlag
Springer Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 3/2020
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-01059-6

Weitere Artikel der Ausgabe 3/2020

Clinical Journal of Gastroenterology 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.